Ennovation Ventures

Ennovation Ventures is a venture capital firm established in 2015, headquartered in Shanghai, China, with an additional office in Nanjing. The firm specializes in investing in early-stage companies within the biomedical and medical health sectors, focusing on areas such as biologics, medical devices, and diagnostics. Ennovation Ventures aims to strategically invest in disruptive new technologies and products within the global biopharmaceutical and medical health industry chain.

The firm's investment strategy emphasizes identifying and supporting innovative companies that have the potential to revolutionize the healthcare landscape. By providing capital and strategic guidance, Ennovation Ventures seeks to foster the growth of companies that are developing cutting-edge solutions in the biomedical field. The firm is committed to becoming a professional investment entity in the biomedicine and medical health sectors.

Ennovation Ventures' portfolio includes investments in companies like Proviva Therapeutics (Shanghai) Co., Ltd., Jiaxing Accunome Biotechnology Co., Ltd., and Nanjing Hippocrates Health Technology Co., Ltd. These investments reflect the firm's dedication to supporting the advancement of medical technologies and healthcare solutions in China. The firm's approach combines financial investment with a deep understanding of the healthcare industry to drive the success of its portfolio companies.